Reduced dietary protein intake does not alter autophagy in human blood: a randomized crossover study in healthy adults
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background & aims
Autophagy activation is a promising strategy to counteract age-related cellular dysfunction. While preclinical studies suggest dietary protein restriction can induce autophagy via mTORC1 inhibition, direct human evidence using dynamic, flux-based measurements remains limited. The aim of this study was to determine whether a low protein diet could modulate autophagic flux in humans.
Methods
We conducted a randomized crossover trial in which 74 healthy adults were randomized to receive two 4-week interventions of either average-protein (20% energy) or reduced-protein (10% energy) diets prescribed to maintain calculated energy balance, separated by a 4-week washout period. The primary outcome was autophagic flux measured in whole blood using a validated assay that preserves PBMCs in their physiological environment during lysosomal inhibition. Secondary outcomes included metabolic markers, body composition, and self-reported health metrics.
Results
Sixty-three participants completed both interventions (mean ± SD age 29.5 ± 7.2 yrs; BMI 24.0 ± 3.2 kg/m 2 ). Reducing protein intake did not alter autophagic flux (adjusted mean difference: −8.46 ng LC3B-II/mg protein/h; 95% CI: −24.06 to 7.14; p = 0.28). Metabolomic profiling confirmed effective dietary separation, with lower circulating urea following reduced protein intake. Small differences in body weight and muscle mass were observed, while fat mass was unaffected. Fasting glucose, insulin, lipids, blood pressure, and quality of life did not differ between the two diets.
Conclusions
Moderate protein restriction does not increase basal autophagy in circulating immune cells of healthy adults, suggesting protein reduction alone, without caloric deficit, may be insufficient to activate autophagy in human blood.
Clinical trial registry number
Australian New Zealand Clinical Trials Registry Identifier ACTRN12623000260628 https://anzctr.org.au/Trial/Registration/TrialReview.aspx?id=382790
